loadpatents
name:-0.009800910949707
name:-0.004694938659668
name:-0.0010499954223633
JUHL; Hartmut Patent Filings

JUHL; Hartmut

Patent Applications and Registrations

Patent applications and USPTO patent grants for JUHL; Hartmut.The latest application filed is for "methods for assessing biological sample quality".

Company Profile
0.4.7
  • JUHL; Hartmut - Hamburg DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods For Assessing Biological Sample Quality
App 20170219587 - JUHL; Hartmut ;   et al.
2017-08-03
Use of an endoplasmin fragment and derivatives thereof as biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
Grant 8,580,489 - Fentz , et al. November 12, 2
2013-11-12
Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
Grant 7,951,528 - Juhl , et al. May 31, 2
2011-05-31
Use of C3a and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
Grant 7,883,842 - Juhl , et al. February 8, 2
2011-02-08
Use Of An Endoplasmin Fragment And Derivatives Thereof As Biomarker For Colorectal Adenoma And/or Carcinoma; Method For Detection And Test System
App 20100273668 - Fentz; Anne-Kristin ;   et al.
2010-10-28
Use of C3a and Derivatives Thereof as a Biomarker for Colorectal Adenoma and/or Carcinoma; Method for Detection and Test System
App 20080160515 - Juhl; Hartmut ;   et al.
2008-07-03
Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
App 20070184499 - Juhl; Hartmut ;   et al.
2007-08-09
Method of creating a collection of biological specimens, and collection of specimens
App 20070048729 - Juhl; Hartmut
2007-03-01
Method for the detection of carcinoembryonic agent and cancer diagnosis method based thereon
App 20060019250 - Juhl; Hartmut ;   et al.
2006-01-26
Cea-expression inhibiting ribozymes and methods for the treatment of cancer based thereon
App 20040138158 - Juhl, Hartmut
2004-07-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed